Complement Therapeutics
Developing the next generation of complement medicines
36 employees · est. 2020 · Germany
True North Therapeutics is the older company (2020 vs 2013); Complement Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Complement Therapeutics | True North Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2013 older |
| Headquarters | ||
| Headquarters | Germany | Not tracked yet |
| Employees | ||
| Employees | 36 larger | 2 |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series A | Series Unknown |
| Total Funding | ||
| Total Funding | $77.00M | $142.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 5 |
| Services | ||
| Services | Research and development of complement-related disease therapies, Development of gene and protein-based therapeutic platforms, Mass spectrometry for complement protein measurement | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with complement-mediated diseases, Individuals with age-related macular degeneration, Healthcare providers specializing in ocular and systemic diseases | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Complement-Mediated Diseases, Gene Therapy, Geographic Atrophy, Dry Age-Related Macular Degeneration, Precision Medicine, Diagnostic Platform, Vision Loss, Retinal Diseases, Complement Cascade, Preclinical Research, Patient Stratification, Efficacy Biomarker, Therapeutic Development | Monoclonal Antibody, Complement Pathway, Rare Diseases, Hematologic Diseases, Renal Diseases, Neurological Diseases, Phagocytosis, Inflammation, Cell Lysis, Drug Development, Spin-out Company, IPierian, Antibody Therapy, Clinical Need |
| Website | ||
| Website | complementtx.com | truenorthrx.com |
About Complement Therapeutics
Complement Therapeutics, founded in 2020, is a biotechnology company dedicated to pioneering the development of the next generation of complement medicines. Headquartered in Germany, this spinout from the University of Manchester focuses on innovative therapeutics for complement-mediated diseases....
About True North Therapeutics
True North Therapeutics is a pioneering biotechnology company founded in 2013 with a mission to selectively inhibit the Complement pathway for diseases of high unmet clinical need. The company's lead monoclonal antibody, TNT009, targets the Classical Complement pathway, enabling selective inhibition...
We will tell you when either one moves
BounceWatch watches Complement Therapeutics and True North Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Complement Therapeutic... and True North Therapeutic... — by email.
Frequently Asked Questions
Compare Complement Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Complement Therapeutics on 28 Jan 2026, and True North Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.